Top Markets
Coin of the day
Alseres Pharmaceuticals, Inc. Alseres Pharmaceuticals, Inc.

Alseres Pharmaceuticals, Inc.

ALSE
Rangering i aksjer #42806
Alseres Pharmaceuticals, Inc. focuses on creating both diagnostic and... Alseres Pharmaceuticals, Inc. focuses on creating both diagnostic and therapeutic solutions, with a primary emphasis on ailments affecting the central nervous system. Their flagship experimental compound is Altropane, a molecular imaging agent developed for identifying and diagnosing Parkinson's disease and dementia. Founded in 1972, the company was previously known as Boston Life Sciences, Inc. before officially changing its name to Alseres Pharmaceuticals, Inc. in June 2007. Its operations are headquartered in Auburndale, Massachusetts.
Aksjekurs
$0.01
Sist synkronisert: 2024-08-19
Markedsverdi
$61.27
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Alseres Pharmaceuticals, Inc. (ALSE)

Kategori

Pris ALSE pris med markedsverdi på B
Alseres Pharmaceuticals, Inc. Alseres Pharmaceuticals, Inc.
ALSE
$0.01
Markedsverdi av Alseres Pharmaceuticals, Inc.(ALSE)
Markedsverdi: $61.27
Per August 2026 har Alseres Pharmaceuticals, Inc. en markedsverdi på $61.27. Dette gjør Alseres Pharmaceuticals, Inc. til det 42806th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Alseres Pharmaceuticals, Inc. fra 1994 til 2026
ALSE sammenlignet med topp 5 mest populære stocks
Pris på ALSE Eiendel B Markedsverdi for B Resultater
Alseres Pharmaceuticals, Inc. Alseres Pharmaceuticals, Inc.
$885,586,506 $61.27
$5.426T +8,855,865,061,892.82%
Alseres Pharmaceuticals, Inc. Alseres Pharmaceuticals, Inc.
$722,525,865 $61.27
$4.427T +7,225,258,645,175.01%
Alseres Pharmaceuticals, Inc. Alseres Pharmaceuticals, Inc.
$675,526,282 $61.27
$4.139T +6,755,262,822,251.89%
Alseres Pharmaceuticals, Inc. Alseres Pharmaceuticals, Inc.
$596,710,248 $61.27
$3.656T +5,967,102,479,460.96%
Alseres Pharmaceuticals, Inc. Alseres Pharmaceuticals, Inc.
$470,972,068 $61.27
$2.886T +4,709,720,679,678.03%